Subscribe to the Wall Street Grapevine Newsletter Now and Get Free Alerts On Stocks Ready To Explode!

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Cytosorbents Corporation (CTSO) Stock Breakout Alert: How to Trade Now?

Cytosorbents Corporation (NASDAQ:CTSO) jumped 17.50% after the FDA approved the company’s Investigational Device Exemption request for DrugSorb-ATR Antithrombotic Removal (ATR) device. With the approval, the company can now move forward with START-T clinical trials evaluating the device in the US for removal of intraoperative ticagrelor during cardiothoracic operation. The company will conduct the study under the Breakthrough Therapy Designation granted in April last year.

The study will evaluate the device in combination with the company’s DrugSorb-ATR. This novel polymer can effectively remove various chemicals and drugs from the bloodstream relative to the standard of care, such as hemodialysis. Most importantly, the IDE grant is not approved for ATR devices as the grant o the request exempts it from conventional steps when launching a new medical device.

Therefore, given the period required to complete the clinical trial and potential market size, it is essential to be patient and wait. Therefore, in the coming weeks, CSTO is a stock to watch.

Market Reaction:

On Tuesday, CTSO stock gained 17.40% at $8.63 with more than 2.75 million shares, compared to its average volume of 216K shares. The stock had moved within a range of $7.43 – 8.76 after opening the trade at $7.80. Over the past 52-week, the stock has been trading within a range of $7.13 – 11.74.

Published by Pete Matthews

Pete attended the University of Colorado and still calls the centennial state home. He chases trout in the summer and snowboards in the winter. He is fascinated with the markets and has a strong interest in nanocap stocks and crypto currency.

Subscribe to the Wall Street Grapevine Newsletter Now and Get Free Alerts On Stocks Ready To Explode!

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Subscribe to the Wall Street Grapevine Newsletter Now and Get Free Alerts On Stocks Ready To Explode!

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
*By submitting your information you agree to the terms of our Privacy Policy. You will receive the DRP Journal newsletter, and third party offers. You can unsubscribe anytime by selecting unsubscribe at the bottom of our emails.